Key Prostate Cancer Updates from ASCO 2025

This chapter reviews key updates from the ASCO 2025 conference, highlighting innovations in prostate cancer treatments and the significance of quality of life in patient management. It also covers recent trial results, including the Amplitude trial on norepirib, and emphasizes the importance of addressing long-term toxicities and financial factors in care.